Antibody to tumor necrosis factor in the treatment of Crohn's disease.
Stricker
T
T
University Children's Hospital, Zurich, Switzerland.
Braegger
C P
CP
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000628:therapy*; D006801:Humans; D000069285:Infliximab; D016032:Randomized Controlled Trials as Topic; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab